// App-Quantinova.ai

1041 : Screening of GBA and LRRK2 G2019S Mutations in Egyptian Parkinson’s Disease Patients

Researchers

Presenter

  • L. R'Bibo

Principal Investigators

  • S. Hamed

  • H. Houlden

  • N. Wood

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • Leucine-rich repeat kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved